| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $155.0M | +6.5% |
| Cost of Revenue | $112.0M | +0.5% |
| Gross Profit | $43.0M | +26.2% |
| R&D Expense | $8.4M | +39.1% |
| SG&A Expense | $84.8M | -20.4% |
| Operating Income | -$110.5M | -40.8% |
| Interest Expense | $14.4M | +86.0% |
| Pre-tax Income | -$123.4M | -0.8% |
| Income Tax | -$1.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.6M | -81.7% |
| Accounts Receivable | $30.1M | +5.2% |
| Current Assets | $54.3M | -73.6% |
| Total Assets | $195.3M | -49.0% |
| Current Liabilities | $35.8M | -48.9% |
| Long-term Debt | $194.4M | -0.1% |
| Total Liabilities | $233.2M | -10.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.9M | -147.3% |
| Capital Expenditures | $769K | +19.2% |
| Investing Cash Flow | -$5.2M | -506.5% |
| Financing Cash Flow | -$103.1M | -157.0% |
| Free Cash Flow | -$49.7M | -143.2% |
| -258.4% |
| Net Income | -$121.7M | +1.5% |
| EPS (Basic) | -$0.95 | +17.4% |
| EPS (Diluted) | -$0.95 | +17.4% |
| Stockholders' Equity |
| -$37.9M |
| -130.9% |